These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1789680)

  • 1. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials.
    Albers GW; Sherman DG; Gress DR; Paulseth JE; Petersen P
    Ann Neurol; 1991 Oct; 30(4):511-8. PubMed ID: 1789680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation and atrial fibrillation.
    Atwood JE; Albers GW
    Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing systemic embolization in patients with atrial fibrillation.
    Cairns JA
    Cardiol Clin; 1994 Aug; 12(3):495-504. PubMed ID: 7805082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing stroke in atrial fibrillation.
    Wolf PA; Singer DE
    Am Fam Physician; 1997 Dec; 56(9):2242-50. PubMed ID: 9402810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation: anticoagulants or not?].
    Zimmermann M
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1560-5. PubMed ID: 7939523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin for atrial fibrillation. The patient's perspective.
    Man-Son-Hing M; Laupacis A; O'Connor A; Wells G; Lemelin J; Wood W; Dermer M
    Arch Intern Med; 1996 Sep; 156(16):1841-8. PubMed ID: 8790079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nonvalvular atrial fibrillation.
    Stettin GD
    West J Med; 1995 Apr; 162(4):331-9. PubMed ID: 7747499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of embolisms in atrial fibrillation: anticoagulation and antiplatelet therapy].
    Kienast J
    Z Kardiol; 1994; 83 Suppl 5():49-58. PubMed ID: 7846945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R; Eccles M; Wood R; Chinn DJ
    Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis.
    Green CJ; Hadorn DC; Bassett K; Kazanjian A
    Can J Cardiol; 1997 Sep; 13(9):811-5. PubMed ID: 9343029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.